Literature DB >> 8969782

Association of chlamydial infection with cerebrovascular disease.

M L Wimmer1, R Sandmann-Strupp, P Saikku, R L Haberl.   

Abstract

BACKGROUND AND
PURPOSE: Recent studies suggest an association of coronary heart disease and carotid atherosclerosis with Chlamydia pneumoniae infection. We investigated the frequency of chlamydial seropositivity and specific circulating immune complexes in patients with recent cerebrovascular disease.
METHODS: Specific antibodies to C pneumoniae in serum were measured by the microimmunofluorescence test in 58 consecutive patients (aged 18 to 50 years) with ischemic infarction (n = 39) or transient ischemic attacks (n = 19) and in 52 hospital control subjects without vascular disease, matched for sex, age, time, and locality.
RESULTS: Twenty-seven patients (46.6%) and 12 control subjects (23.1%) had raised IgA titers > or = 1:16 (P = .018). IgG titers > or = 1:32 were measured in 74.1% of the patients and 77% of control subjects (P = .623). Specific IgG antibodies in circulating immune complexes, which were isolated by polyethylene glycol precipitation, were elevated > or = 1:8 in 24.1% of the patients and 7.7% of control subjects (P = .047). With the use of a conditional logistic regression model, the odds ratios were 1.70 (95% confidence interval [CI], 1.13 to 2.58) for elevated IgA titers, 1.91 (95% CI, 1.06 to 3.47) for the presence of immune complexes, and 1.96 (95% CI, 1.00 to 3.82) for the presence of both factors. After adjustment for the vascular risk factors hypertension, age, sex, and migraine, the odds ratios were 1.71 (95% CI, 1.08 to 2.70), 2.00 (95% CI, 1.07 to 3.76), and 2.20 (95% CI, 1.09 to 4.41), respectively.
CONCLUSIONS: We conclude that chronic infection with C pneumoniae is associated with an increased risk of stroke and transient ischemic events.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969782     DOI: 10.1161/01.str.27.12.2207

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.

Authors:  Olga Tapia; Anatoly Slepenkin; Evgueni Sevrioukov; Kathi Hamor; Luis M de la Maza; Ellena M Peterson
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

3.  Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study.

Authors:  Søren P Johnsen; Kim Overvad; Lars Ostergaard; Anne Tjønneland; Steen E Husted; Henrik T Sørensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 4.  New and emerging infectious diseases.

Authors:  G L Mandell; G C Townsend
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

5.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

6.  Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNA.

Authors:  D Palfrey; P J Cook; J A Smythe; G Y Lip; A V Hine
Journal:  Mol Pathol       Date:  1999-10

7.  Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers.

Authors:  Ali K Adiloglu; Rabia Can; Cem Nazli; Ahmet Ocal; Oktay Ergene; Gulgun Tinaz; Nesimi Kisioglu
Journal:  Tex Heart Inst J       Date:  2005

8.  Association between Chlamydia pneumoniae IgG antibodies and migraine.

Authors:  QiHong Lu; Jinzh Xu; HongYan Liu
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

9.  Infectious burden and risk of stroke: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Pankajavalli Ramakrishnan; Yeseon P Moon; Bernadette Boden-Albala; Khin M Liu; Steve L Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Arch Neurol       Date:  2009-11-09

10.  Genus-optimized strategy for the identification of chlamydial type III secretion substrates.

Authors:  Kelley M Hovis; Sergio Mojica; Jason E McDermott; Laura Pedersen; Chana Simhi; Roger G Rank; Garry S A Myers; Jacques Ravel; Ru-ching Hsia; Patrik M Bavoil
Journal:  Pathog Dis       Date:  2013-08-14       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.